Amylyx Pharmaceuticals, Inc. (AMLX)
28.91
-0.29
(-0.99%)
USD |
NASDAQ |
Nov 04, 14:08
Amylyx Pharmaceuticals Price to Book Value : 13.46 for Nov. 4, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 13.60 |
| November 02, 2026 | 13.06 |
| October 30, 2026 | 13.44 |
| October 29, 2026 | 13.35 |
| October 28, 2026 | 13.07 |
| October 27, 2026 | 13.18 |
| October 26, 2026 | 12.61 |
| October 23, 2026 | 12.67 |
| October 22, 2026 | 13.30 |
| October 21, 2026 | 13.52 |
| October 20, 2026 | 13.40 |
| October 19, 2026 | 12.73 |
| October 16, 2026 | 12.27 |
| October 15, 2026 | 12.88 |
| October 14, 2026 | 12.59 |
| October 13, 2026 | 12.50 |
| October 12, 2026 | 12.80 |
| October 09, 2026 | 13.10 |
| October 08, 2026 | 12.67 |
| October 07, 2026 | 12.77 |
| October 06, 2026 | 13.06 |
| October 05, 2026 | 12.94 |
| October 02, 2026 | 12.94 |
| October 01, 2026 | 13.08 |
| September 30, 2026 | 13.55 |
| Date | Value |
|---|---|
| September 29, 2026 | 13.63 |
| September 28, 2026 | 13.90 |
| September 25, 2026 | 13.73 |
| September 24, 2026 | 14.03 |
| September 23, 2026 | 14.25 |
| September 22, 2026 | 15.37 |
| September 21, 2026 | 15.08 |
| September 18, 2026 | 15.09 |
| September 17, 2026 | 15.80 |
| September 16, 2026 | 15.19 |
| September 15, 2026 | 15.44 |
| September 14, 2026 | 15.66 |
| September 11, 2026 | 14.72 |
| September 10, 2026 | 14.94 |
| September 09, 2026 | 15.09 |
| September 08, 2026 | 15.78 |
| September 04, 2026 | 15.88 |
| September 03, 2026 | 15.81 |
| September 02, 2026 | 16.06 |
| September 01, 2026 | 15.74 |
| August 31, 2026 | 15.72 |
| August 28, 2026 | 16.18 |
| August 27, 2026 | 17.31 |
| August 26, 2026 | 17.27 |
| August 25, 2026 | 17.44 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pfizer Inc. | 2.052 |
| Eli Lilly & Co. | 33.30 |
| Merck & Co., Inc. | 8.749 |
| Bristol Myers Squibb Co. | 5.525 |
| ANI Pharmaceuticals, Inc. | 2.776 |
Price to Book Value Related Metrics
| Price | 28.91 |
| Earnings Yield | -4.96% |
| Market Cap | 3.220B |